
Gilead Sciences
Gilead Sciences is Harnessing the Power of AI and Cloud to Accelerate Drug Discovery for Virology, Inflammation and Oncology
AI and Cloud Technologies Enable More Patients to Access Life-Saving Treatment
Gilead Sciences transformed treatment for people living with serious diseases, such as HIV and COVID-19. Now, in partnership with AWS, Gilead is using data, AI, and cloud technologies to develop life-saving treatments for intractable conditions such as cancers of the blood, lupus and hepatitis.
More ExecLeader Customer Success Stories
On Demand content
Watch past event content on demand